Medical News

RSS

Today's opinions and editorials

Political intimidation has always been part of the current Congress's health-care strategy: "If you're not at the table, you're on the menu" is tattooed on every lobbyist and industry rep in Washington. But Max Baucus's latest bullying tactics are hard to believe by even these standards, as the Senate Finance Chairman has sicced federal regulators on the insurer Humana Inc. for daring to criticize one part of his health bill (9/22).

23 Sep 2009

Baucus: Several changes to make health bill affordable for middle class

"Under pressure from fellow Democrats, the chairman of the Senate Finance Committee endorsed additional measures to defray the cost of insurance for working class families on Tuesday as the panel opened debate on sweeping health care legislation,"

23 Sep 2009

BioMarin commences PEG-PAL Phase 2 clinical trial for phenylketonuria

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that the first patient has initiated treatment in the Phase 2 clinical study of PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of phenylketonuria (PKU). Initial top-line results are expected in mid-2010.

23 Sep 2009

New AIDS treatment center to open in Washington, DC

AIDS Healthcare Foundation (AHF), the US’ largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening of AHF’s first AIDS treatment center in Washington, DC, where the HIV rate is now reported to be 3%—higher than the rate in Lagos, Nigeria.

23 Sep 2009

Chan calls for additional H1N1 vaccines for poor countries during WHO Asia-Pacific regional meeting

During the WHO Asia-Pacific regional meeting Monday, WHO Director-General Margaret Chan discussed the organization's efforts to ensure that poor nations have access to H1N1 vaccines, VOA News reports (Bayron, 9/21).

23 Sep 2009

Government orders additional H1N1 vaccine

Associated Press/Boston Globe reports that on Monday, "the United States ordered more swine flu vaccine, bringing its eventual total to 251 million doses, up from the long-planned 195 million doses.

23 Sep 2009

After criticisms, Baucus expects big changes to health bill

The Senate Finance Committee is meeting beginning today to consider chairman Max Baucus' health proposal and is very likely to make substantial changes.

23 Sep 2009

Search for a Super Community program launched by BC Children's Hospital

BC Children's Hospital Foundation is calling on BC communities of all shapes, sizes and definitions to participate in its Search for a Super Community. The program, launched on September 21 on Global BC TV, gives communities across the province an opportunity to raise their profile while helping raise awareness of the need for a new BC Children's Hospital.

23 Sep 2009

HealthRock to promote health education

The $1 trillion cost and massive government role envisioned by the Obama Administration’s health care reform plan (The Affordable Health Choices Act of 2009) continue to create controversy in Congress and throughout the nation.

23 Sep 2009

African leaders to form alliance to eliminate malaria deaths

African leaders, who are scheduled to meet in New York on Wednesday, are expected to launch an effort - the African Leaders Malaria Alliance (ALMA) - to eliminate all malaria deaths on the continent by 2015, the Daily Independent/allAfrica.com reports (Shokunbi, 9/22).

23 Sep 2009

$1.2 million grant to study centrosomes and cilia and their connections to human disease

If you don't know how a human cell is supposed to work, it's hard to offer a good explanation when the cell goes haywire -- as it does in cancer. That's why a Florida State University College of Medicine researcher has been awarded a $1.2 million grant to explore the role of centrosomes and cilia in cell division and development and their connections to human disease.

22 Sep 2009

ONA appeals against Ministry of Labour's decision in London nurse's death investigation

The Ontario Nurses' Association (ONA) is appealing the decision by a Ministry of Labour inspector to not issue orders against London Health Sciences Centre or make recommendations for improvements in procedures and practices following the death of one of its registered nurses of methicillin-resistant staphylococcus aureus (MRSA).

22 Sep 2009

U.S. FDA bans flavored cigarettes

One of the first provisions of the new federal law regulating tobacco products will take effect Tuesday as the U.S. Food and Drug Administration (FDA) enforces a ban on candy, fruit and other flavored cigarettes.

22 Sep 2009

Sanofi Pasteur receives additional order H1N1 vaccine

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the company has received an additional order from the U.S. Department of Health and Human Services (HHS) to produce vaccine to help protect against the Influenza A (H1N1) 2009 virus. The new order is for the production of bulk antigen equivalent to 27.3 million doses based on 15 mcg of antigen per dose.

22 Sep 2009

The YAI Network launches new website to support people with disabilities

The YAI Network (YAI), one of America’s foremost non-profit organizations devoted to creating hope and opportunity for people with developmental and learning disabilities and their families, announced today the introduction of a new Web site at www.yai.org. The new site provides visitors with a crisp and clear presentation of the organization’s mission and opportunities to engage with the network to support people with disabilities as well as access services and information.

22 Sep 2009

New research poll reveals that Canadians rate physicians and pharmacists highest in honesty and ethics

According to a new Nanos Research poll, Canadians rate physicians and pharmacists highest among 18 professions, when it comes to honesty and ethics. Seventy-seven per cent of respondents call medical doctors' standards of honesty and ethics "high" or "very high", while the figure was 73 per cent for community pharmacists.

22 Sep 2009

Advaxis' patent approval enables the development of new vaccines with additional properties

The United States Patent and Trademark Office (USPTO) has granted and issued Advaxis, Inc. (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, patent 7,588,930 “Compositions and Methods for Enhancing Immunogenicity of Antigens.” This patent expands the Company’s intellectual property portfolio to cover another family of adjuvant proteins based upon the Lm protein Act-A.

22 Sep 2009

Annual EmTech@MIT conference to showcase important emerging technologies

Are you interested in seeing groundbreaking demos of the most sophisticated and innovative technologies of today? The annual EmTech@MIT conference gives you access to the newest labs, companies, and entrepreneurs from around the world. EmTech@MIT brings Technology Review’s mission to life by showcasing the most important emerging technologies and explaining their impact. EmTech@MIT is packed with groundbreaking demos, thought-provoking keynotes, interactive breakout sessions, and opportunities for exclusive networking with our senior-level audience.

22 Sep 2009

Astellas partners with NSTA to sponsor a year-long program for science educators

Astellas Pharma US, Inc. ("Astellas"), in partnership with the National Science Teachers Association (NSTA), is pleased to welcome its second-year class of Chicago-area science teachers to participate in the 2009 NSTA New Science Teacher Academy.

22 Sep 2009

Oncotype DX Recurrence Score provides consistent results across varied patient populations

Genomic Health, Inc. today, announced results from the first study to compare the distribution of Oncotype DX® Recurrence Score® results between European, Middle Eastern and United States patient populations.

22 Sep 2009

Medical News

Today's opinions and editorials

Baucus: Several changes to make health bill affordable for middle class

BioMarin commences PEG-PAL Phase 2 clinical trial for phenylketonuria

New AIDS treatment center to open in Washington, DC

Chan calls for additional H1N1 vaccines for poor countries during WHO Asia-Pacific regional meeting

Government orders additional H1N1 vaccine

After criticisms, Baucus expects big changes to health bill

Search for a Super Community program launched by BC Children's Hospital

HealthRock to promote health education

African leaders to form alliance to eliminate malaria deaths

$1.2 million grant to study centrosomes and cilia and their connections to human disease

ONA appeals against Ministry of Labour's decision in London nurse's death investigation

U.S. FDA bans flavored cigarettes

Sanofi Pasteur receives additional order H1N1 vaccine

The YAI Network launches new website to support people with disabilities

New research poll reveals that Canadians rate physicians and pharmacists highest in honesty and ethics

Advaxis' patent approval enables the development of new vaccines with additional properties

Annual EmTech@MIT conference to showcase important emerging technologies

Astellas partners with NSTA to sponsor a year-long program for science educators

Oncotype DX Recurrence Score provides consistent results across varied patient populations

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Latest News